SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-119339
Filing Date
2016-08-15
Accepted
2016-08-15 15:37:17
Documents
57
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v445894_10q.htm 10-Q 507702
2 EXHIBIT 31.1 v445894_ex31-1.htm EX-31.1 8723
3 EXHIBIT 31.2 v445894_ex31-2.htm EX-31.2 8475
4 EXHIBIT 32.1 v445894_ex32-1.htm EX-32.1 4897
5 EXHIBIT 32.2 v445894_ex32-2.htm EX-32.2 5175
  Complete submission text file 0001144204-16-119339.txt   2921844

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nspx-20160630.xml EX-101.INS 512115
7 XBRL TAXONOMY EXTENSION SCHEMA nspx-20160630.xsd EX-101.SCH 34847
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nspx-20160630_cal.xml EX-101.CAL 20597
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nspx-20160630_def.xml EX-101.DEF 202433
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nspx-20160630_lab.xml EX-101.LAB 243432
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nspx-20160630_pre.xml EX-101.PRE 235015
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 161832300
SIC: 2834 Pharmaceutical Preparations